The treatment has been initiated in the laboratory of Associate Professor Alexandru Schiopu, at Lund University.

Dr. Alexandru Schiopu is a Consultant in Internal Medicine and specialist in Cardiology at Skane University Hospital in Lund, Sweden.

CALPROTECT AB is a Lund University spin-off based in Malmö, Sweden.